15.06.2015
- Following shareholder approval of the name change on Jun 5, Iceland-based generic drugmaker Actavis has begun trading as Allergan. The name change follows the Botox manufacturer’s...
08.06.2015
- An unusual lawsuit claiming the Food and Drug Administration (FDA) overstepped its bounds by deciding that two generic drugs used to treat attention deficit hyperactivity disorder...
28.05.2015
- Under a ruling by a US court of appeals upholding a preliminary injunction dating from December 2014, Ireland-headquartered former US drugmaker Actavis will have to continue...
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
16.03.2015
- Dublin, Ireland-based Endo International has made a takeover bid for US drugmaker Salix Pharmaceuticals in an effort to thwart Valeant Pharmaceuticals International's $10 billion...
04.03.2015
- AstraZeneca has completed its acquisition of the rights to Actavis' branded respiratory business in the US and Canada. The UK-Swedish drugmaker said the buy strengthens its...
03.03.2015
- The US Food and Drug Administration has approved the hormonal intrauterine contraceptive (IUD) Lileta, which releases the hormone levonorgestrel to inhibit thickening of the womb...
25.02.2015
- With activist investors continuing to make headlines in the chemical industry, especially in the US, the struggles of Dow, DuPont and Botox producer Allergan are cases in point -...
